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This study aimed to investigate the anti-inflammatory, anti-arthritic and immuno-regulatory effects of
electro-acupuncture (EA) at ST36 on Collagen-induced arthritis (CIA) in mice. Male DBA/1J mice were
divided into five groups: Normal, Control, NR (needle retention), EAI and EAII. All mice except those
in the normal group were immunized with Collagen II for arthritis induction. Acupuncture needles
were inserted into mice ST36 and electrical currents at a frequency of 2 Hz in a continuous rectangular
wave form were conducted through the needles for 15 min, 3 times a week. EA treatments were
administered for 5 weeks in the EAI group and for 9 weeks in the EAII group. The mice in the NR group
were acupunctured in the same manner as the EA groups and the needles were retained for 15 min
without electrical stimulation. CIA incidence analysis, ELISA, histological analysis and FACS analysis
were performed to evaluate the effect of EA on CIA. EA at ST36 significantly reduced CIA incidence,
IL-6, TNF-a, INF-g, collagen II antibody, IgG and IgM levels in CIA mice serum and prevented knee
joint destruction. EA at ST36 also reduced CD69þ/CD3eþ cells and CD11aþ/CD19þ cells in CIA
mice lymph nodes, and CD11bþ/Gr1þ cells in CIA mice knee joints. The ratios of CD3eþ cells to
CD19þ cells, and CD8þ cells to CD4þ cells were maintained closer to the normal range in the EA
groups as compared with the control group or the NR group. EAII was more effective than EAI
throughout all the measurements. The NR was effective as well, though less effective than EA. EA at
ST36 may have an anti-inflammatory, anti-arthritic and immuno-regulatory effects on CIA in mice. The
effectiveness is stronger when EA starts earlier and is applied longer. Needle retention without electrical
stimulation may be effective on CIA as well, however less effective than EA. Electrical stimulation and
acupoint ST36 may have synergistic effects on CIA.
Keywords: Electro-acupuncture (EA) – ST36 – Collagen-induced arthritis (CIA) – Rheumatoid
arthritis (RA)
INTRODUCTION
Acupuncture is one of the oldest therapeutic interventions in
the world and is now widely accepted for pain relief not only
in the East but in the West as well (1). Besides pain relief,
acupuncture is also considered to be effective for nausea and
vomiting (2), bronchial asthma (3), musculoskeletal disorders
(3) and immuno-inflammatory conditions such as rheumatoid
arthritis (RA) (5,6,7) etc.
RA is a systemic inflammatory disorder that affects the
diathrodial joint (8). Although acupuncture is often used for
the patients with RA in the clinical situation, scientific
evidence is lacking (9–12).
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acupuncture on RA. For this purpose, we decided to use
electro-acupuncture (EA) to objectify the amount of acupunc-
ture stimulation on an experimental animal model of
collagen-induced arthritis (CIA).
Acupoint ST36 (stomach 36) is the most commonly used
acupoint for the purpose of immune strengthening and immune
regulation (strengthening and regulating Qi and Blood in
oriental medical terminology) in oriental medical clinics (13).
Moreover, in Oriental medical theory, since the Spleen &
Stomach govern the four limbs, acupoints on the Spleen &
Stomach meridians are often used for disorders of the four
limbs (14). Among the acupoints on the Stomach meridian,
ST36 is the ‘Sea He’ point of the stomach that is important as
the entry point of the Stomach meridian energy to the Stomach
organ. ST36 is also the earth natured point of the earth natured
(Stomach) meridian and could be the representative point of
the Stomach meridian. ST36 is therefore considered to be
stronger than the other ST points (15). On the basis of these
theories, ST36 seemed to be the best choice for an immune
related disease with symptoms in the four limbs (distal joints),
such as RA.
METHODS
1. Mice
5 weeks old male DBA/1J mice were purchased from SLC,
Inc. (Shizuoka, Japan). They were allowed 1 week to adapt to
the environment (22 ± 2 C, 12 hr light/dark cycle). Mice had
free access to water and food (Superfeed, Korea). Our animal
experiment was conducted in accordance with the Use of
Laboratory Animals as adopted and promulgated by the U.S.
National Institutes of Health.
2. CIA mouse model
Type II collagen extracted from bovine articular cartilage
(CII, Chondrex, USA) was dissolved in 0.05 M acetic acid
(2 mg/ml) at 4 C overnight. Then the solution was emulsified
in an equal volume of complete Freund’s adjuvant (CFA,
Chondrex, USA) (16,17). Mice were injected intradermally at
the base of the tail with 0.2 ml of the emulsion. 21 days after
the primary immunization, mice were boosted with the same
volume of the emulsion (18) (Scheme 1).
3. Electro-acupuncture
The mice were divided into five groups: normal; control; NR
(needle retention); EA (electro-acupuncture) I and EAII. Each
group consisted of 10 mice. Small cages with five holes for
four limbs and a tail were built. During acupuncture
administration, the animals were maintained within the cage
with right hind limb taken out and fastened to the wall of the
cage with tape. Sterilized disposable stainless steel acupunc-
ture needles (0.25 · 30 mm, Dongbang Acupuncture, Inc.
Korea) were inserted perpendicularly as deep as 2–3 mm at
right ST36. Mice ST36 was determined according to human
ST36 which is located on the stomach meridian, longitudinally
three body inches below the knee joint, transversely in the
middle of the tibialis anterior muscle. For a better point
detection in mice, we used an elastic rubber band which was
stretched along a ruler and three points at 0, 3 and 16 cm on the
rubber band were marked with a red pen. The rubber band was
then set to mouse right hind limb with the first mark at 0 cm on
the rubber band adjusted to mouse ST35 (a point located at the
lower border of patellar, in the depression lateral to the patellar
ligament) (19), and the last mark at 16 cm on the rubber band
adjusted to mouse ST41 (a point located on the dorsum of foot,
at the midpoint of the transverse crease of the ankle joint, in the
depression between the tendons of m. extensor digitorum
longus and hallucis longus) (19). The point that corresponded
to the second (middle) mark on the rubber band was
determined as ST36. After a needle was inserted at right
ST36, an electrode (0.5 · 1c m
2) was attached to right ST41.
An electro-stimulator (PG-306, Japan) was connected to the
handle of the acupuncture needle inserted at right ST36, and to
the electrode attached to right ST41 (Figure 1). The mice in the
EA groups were electrically stimulated with a 2 Hz current in a
rectangular wave form for 15 min, 3 times a week. The
intensity (6-7mA) was adjusted until local muscle contractions
were seen. The mice in EAI group were treated with EA for
5 weeks starting 4 weeks after the booster immunization, while
those in EAII group were treated for 9 weeks, starting right
Scheme 1. Experimental procedure. The total experiment took 12 weeks. The animals were immunized with CII at the beginning of the experiment and boosted
3 weeks later. Restriction within the cage in control group, needle retention in NR group and EA in EAI group started at the 7
th week and were conducted for
5 weeks. EA in the EAII group started at the 3
rd week and was conducted for 9 weeks.
52 Effect of EA at ST36 on CIAafter the booster immunization. The period of EAII was
4 weeks longer than that of EAI, and we could observe the
protective effect of EA against CIA. The mice in the NR group
were acupunctured in the same manner as the EA groups and
the needles were retained for 15 min without electrical
stimulation. The mice in the control group were maintained
in the cage for 15 min without acupuncture administration
(Scheme 1).
4. Determination of CIA incidence
Starting a week after the booster immunization, arthritic
incidence of mice in each group was determined weekly based
on the number of arthritic limbs and the arthritis scores with
range of 0 to 4 (score: 0 ¼ no change, 1 ¼ light swelling and
erythema of the mid foot or tarsal bone or the ankle joint,
2 ¼ mild swelling and erythema of the mid foot or tarsal bone
through the ankle joint, 3 ¼ moderate swelling and erythema
of the ankle joint through the metatarsal bone, and 4 ¼ gross
swelling and erythema of the ankle joint through the digit)
(16). CIA was regarded as induced when the score was higher
than 1in more than two limbs or higher than 2 in more than one
limb. CIA incidence of each group was estimated by a formula
(incidence ¼ number of CIA mice/total number of mice · 100).
5. Fluorescence-activated cell sorter (FACS) analysis
Inguinal lymph nodes were removed aseptically and pressed
through steel mesh to make a single cell suspension with RPMI
1640. Mouse knee joints were removed and chopped in RPMI
1640. Joint cells were isolated with collagenase type II
(1mg/ml; Sigma, USA) in a shaking incubator for 30 min.
For double fluorescence staining, purified single cells from
lymph nodes or knee joints were stained with Fluorescein
(FITC)-anti-mouse CD3e plus Phycoerythrin (PE)-anti-mouse
CD69, or FITC-anti-mouse CD19þ plus PE-anti-mouse
CD11a, or FITC-anti-mouse CD4 plus PE-anti-mouse CD8,
or FITC-anti-mouse Gr1 plus PE-anti-mouse CD11b for
1hr. After washing twice with washing buffer (1 · PBS with
2% BSA), the cells were analyzed by flow cytometory
(FALCON, USA).
6. Enzyme-linked immunosorbent assay (ELISA)
analysis for immunoglobulin
Serum was isolated from individual animals and frozen at
 70 C. ELISA plates (Biosource, USA) were coated with
25 mg/ml bovine collagen II peptide in 100 mlo f1· PBS
overnight at 4 C. Plates were then washed with washing buffer
(1 · PBS with 0.05% Tween) and blocked with 200 mlo f
blocking buffer (3% BSA, 0.05% Tween with 1 · PBS) for 2 h
at 37 C. Plates were washed and 100 ml of diluted serum
samples were added in triplicaes each for rheumatoid factor
IgG and IgM and incuvated at 37 C for 90 min. Plates were
washed and 100 ml of 1/5000 dilution of either 0.5 mg/ml
biotin-anti-mouse IgG or IgM was added and incubated for 1hr
at 37 C. Plates were washed and 100 ml of 1/1000 dilution of
1 mg/ml avidin peroxidase was added and incubated for
30 min at RT or 37 C. Plates were washed and 100 mlo fT M B
microwell substrate solution was added and allowed to
develop for 10 min. Absorbance (450 nm) was measured
with an ELISA plate reader (TECAN, Canada). The antibody
levels were evaluated with an ELISA kit (Shibayagi, Japan)
according to the manufacturer’s protocol.
7. Enzyme-linked immunosorbent assay (ELISA)
analysis for cytokines
IL-6, TNF-a, and INF-g were detected using standard
sandwich cytokine ELISA. IL-6, TNF-a, and INF-g were
detected using mouse cytokine ELISA kit from Biosource
(USA) according to manufacturer’s protocol. Briefly, plates
were coated with anti-mouse cytokine capture antibody and
supernatants were plated and allowed to incubate for 2 h.
Plates were then washed and a biotinylated anti-mouse
cytokine plus horseradish peroxidase conjugate was added
and incubated for 1 h. Plates were then developed with TMB
microwell substrate solution and stopped with TMB stop
solution and allowed to develop for 10 min. The absorbance
(450 nm) was measured with an ELISA plate reader (TECAN,
Canada).
8. Histological analysis
The knee joint was removed from each mouse and washed in
PBS, and infused with 10% formalin in PBS for fixations.
Formalin-fixed explants and nonimplanted, treated knee joint
samples (n ¼ 3/group) were embedded in paraffin. Sections
(6 mm) were deparaffinized in xylene followed by dehydration
in a graded series of ethanol to water. Hematoxylin and eosin
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Fig. 1. Schematic drawing of electro-acupuncture at right ST36.
Acupuncture needles (0.25 · 30 mm) were inserted perpendicularly as deep as
2–3 mm at right ST36 of mice. An electro-stimulator (PG-306, Japan) was
connectedto the handleof the acupunctureneedle insertedat right ST36and an
electrode attached to right ST41.
eCAM 2007;(4)1 53(H&E) staining was performed on all samples to observe
general morphology of tissues. Masson’s Trichrome (MT)
staining (Bay Shore, NY) was used to examine collagen fibers
in the tissues. Condition of cartilage surface, cynoviocytes
proliferation, pannus formation, bone erosion and inflammation
in the knee joint were observed at a magnification of 200·.
9. Statistical analysis
Data were expressed as mean ±SEM and analyzed using a
one-way analysis variance (ANOVA) followed by a t-test. The
criterion for significance was p < 0.05. Since the difference
between the normal group and the control group was clearly
distinguished, statistical significance between the normal
group and the control group was not shown in the figures to
put an emphasis on the statistical differences between the
experimental groups and the control group or the NR group.
RESULTS
1. CIA incidence
Collagen II immunization induced arthritis in mice with the
rate of 80%. The incidences of CIA in the EA groups were
lower than that of the control group. CIA incidence of EAII
group was the lowest and subsequently those of EAI and NR
groups followed (Fig. 2).
2. Levels of cytokines and antibodies in CIA
mouse serum
Collagen II immunization remarkably increased IL-6, INF-g,
TNF-a, IgG, IgM and anti-collagen II antibody levels in serum
as compared with those of the normal group. On the other
hand, all those measures were reduced significantly by EA at
ST36 in comparison with the control group or NR group. All
the measurements showed greater reductions in EAII group
than those in EAI group, though statistical significance was not
found between EAI and EAII groups (Fig. 3).
3. Histology of CIA mouse knee joint
Collagen II immunization induced severe joint destruction in
mice. Severe cartilage surface erosion, cynoviocytes prolif-
eration, pannus formation, bone erosion and inflammation
were found in the control group. EA at ST36 prevented these
pathological changes in CIA. (Fig. 4).
4. Immune cell population in CIA mouse lymph node
and knee joint
ThepopulationsofCD69þ/CD3eþcellsandCD11aþ/CD19þ
cells in mouse lymph nodes were remarkably increased in the
control group as compared with the normal group. On the other
hand, CD69þ/CD3eþ cells in EA groups were reduced
significantlyincomparisonwiththecontrolgroup.Thenumber
of CD69þ/CD3eþ cells in EAII group was significantly lower
than that of EAI group. EA at ST36 reduced CD11aþ/CD19þ
cells as well but statistical significance was not found
(Fig. 5). Also the ratios of CD19þ cell / CD3eþ cell (B cell /
T cell) and CD8þ/CD4þ cell (CD8 T cell/CD4 T cell) in CIA
mouse lymph node were maintained closer to the normal range
in EA groups as compared with the control group or NR group
(Fig. 6). CD11bþ/Gr1þ cell population in CIA mouse
knee joint was increased by Collagen II immunization and
significantly reduced by EA at ST36 (Data not shown).
DISCUSSION
RA is a systemic autoimmune disease characterized by chronic
articular inflammation and progressive joint destruction (8).
CIA is an animal model of human rheumatoid arthritis that can
be induced in susceptible mice by immunization with type II
collagen (CII) (20). We used CIA model to investigate the
effect of EA on RA.
In our study, CIA incidence was reduced and histological
destruction of joint was prevented by EA at ST36 (Fig. 2,
Fig. 4). These results suggested that EA at ST36 may reduce
arthritis incidence and prevent joint destruction in CIA.
RA is an immune-mediated disease for which an autoimmune
pathogenesis is postulated (21). All components of the immune
system are involved in mediating tissue damage and systemic
inflammation in RA. T cells, B cells, and macrophages infiltrate
into the synovium and form highly sophisticated lymphoid
structures.Cytokinesareproducedbymacrophagesandactivated
tissue-resident cells. As a consequence of T cell and B cell
responses, bone is eroded and cartilage is destroyed (22).
TNF-a is considered to be related to the process of
synovititis and joint destruction in RA, and treatment of
murine models of arthritis with antibodies against TNF-a
ameliorates or abrogates disease (8). IL-6 also contributes to
joint inflammation in RA, and has been the target of RA
treatment with an anti-IL-6 receptor antibody. INF- g is known
to increase in RA (23–25). In the present study, CII
Fig. 2. CIA incidence in mice. CIA Incidence (%) was determined by
observation of mice limbs, according to the number of arthritic limbs and the
arthritis scores (scores described in Materials and Methods). CIA was
considered to have been induced when the score was higher than 1 in more
than two limbs or higher than 2 in more than one limb. Incidence ¼ number of
CIA mice/total number of mice· 100. Control: CII injection, NR: CII injection
and needle retention at ST36, EAI: CII injection and EA at ST36 for 5 weeks,
EAII: CII injection and EA at ST36 for 9 weeks.
54 Effect of EA at ST36 on CIAimmunization remarkably increased serum TNF-a, IL-6 and
INF-g levels, while, EA at ST36 significantly reduced the
elevated serum TNF-a, IL-6 and INF- g in comparison with
the control group or the NR group (Fig. 3). CD11bþ/Gr1þ
cell population in CIA mouse knee joint was also
reduced significantly by EA at ST36, indicating that EA at
ST36 reduced inflammatory granulocytes in CIA mouse
knee joints (Data not shown). From these results, we
speculate that EA at ST36 may have an anti-inflammatory
effect on CIA.
Immunization of susceptible strains of animals with native
CII in adjuvant results in CIA (26,27), therefore autoimmunity
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Fig. 3. IL-6, INF-g, TNF-a, IgG, IgM and collagen II antibody in mouse serum. Serum IL-6, INF-g, TNF-a, IgG, IgM and collagen II antibody levels were
determined by ELISA. They were increased remarkably by CII injection and significantly reduced by EAs. Control: CII injection, NR: CII injection and needle
retention at ST36, EAI: CII injection and EA at ST36 for 5 weeks, EAII: CII injection and EA at ST36 for 9 weeks. Data were expressed as mean ±SD. *: p<0.05,
**: p<0.01, ***: p<0.001 compared with control group,
##:p <0.01,
###:p <0.001 compared with NR group.
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Fig. 5. CD69þ/CD3eþ and CD11aþ/CD19þ cell populations in mouse lymph node. The populations of CD69þ/CD3eþ cells and CD11aþ/CD19þ cells in
CIA mice lymph nodes were analyzed by flow cytometer three times for each. Both were increased by CII administration and reduced by EA stimulation. CII
injection, NR: CII injection and needle retention at ST36, EAI: CII injection and EA at ST36 for 5 weeks, EAII: CII injection and EA at ST36 for 9 weeks. Data
were expressed as mean ±SD. **: p<0.01, ***: p<0.001 compared with control group,
xx:p <0.01 compared with EAI group.
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Fig. 6. Ratios of CD3eþ cells to CD19þ cells and CD4þ cells to CD8þ cells in mouse lymph node. The populations of CD3eþ, CD19þ, CD4þ and CD8þ
cells in CIA mouselymphnode wereanalyzed by flowcytometer threetimes foreach,and the ratiosofCD3eþ cells to CD19þ cells andCD4þcells to CD8þ cells
were estimated. The ratios were reduced by CII immunization, while they seemed to be recovered close to the normal range by EAs. Control: CII injection, NR: CII
injection and needle retention at ST36, EAI: CII injection and EA at ST36 for 5 weeks, EAII: CII injection and EA at ST36 for 9 weeks.
Fig. 4. Histology of mouse knee joint. The knee joint was obtained from each mouse. Formalin-fixed knee joint samples (n¼3/group) were embedded in paraffin.
Sections (6 mm) were stained with Hematoxylin and eosin (H&E) (Top) or Masson’sTrichrome (MT) (Bottom). Severe cartilage destruction and other pathological
changes could be found in the control group while milder changes were found in EA groups. Control: CII injection, NR: CII injection and needle retention at ST36,
EAI: CII injection and EA at ST36 for 5 weeks, EAI: CII injection and EA at ST36 for 9 weeks. Magnification, ·200.
56 Effect of EA at ST36 on CIAto CII is implicated in pathogenesis of CIA. In the present
study, CII immunization remarkably increased collagen II
antibody, IgG and IgM levels in mice serum, while EA at ST36
significantly reduced these levels in comparison with the
control group or the NR group. These results suggest that EA at
ST36 may suppress autoimmunity in CIA (Fig. 3).
T cells and B cells are key participants in the pathogenesis of
RA (8,28,29). Activated T cells promote the disease progres-
sion by inducing the secretion of proinflammatory cytokines
from macrophages and synovial cells. Rheumatoid factor (RF)
B cells also play a critical role in RA (30). In the present study,
CD69þ/CD3eþ cells and CD11aþ/CD19þ cells in mouse
lymph nodes were increased significantly by CII immunization
and reduced remarkably by EA at ST36, indicating EA at ST36
reduced activated T cells and activated B cells in mouse lymph
nodes (Fig. 5). These results suggest that EA at ST36 may have
a suppressive effect on T cell and B cell activation in CIA.
Besides the reduction of activated lymphocytes population,
EA at ST36 seems to aid the recovery of the ratios of T cells to
B cells and CD4 T cells to CD8 T cells in mouse lymph node
close to the normal range (Fig. 6).
Acupuncture without electrical stimulation showed a similar
tendency but was weaker than those of EA on CIA. From this
result, we presume that needle retention itself is beneficial to
relieve or treat CIA, but supplement of electrical stimulation
intensifies its effects, indicating acupoint ST36 and electrical
stimulation may have synergistic effects on CIA.
From the results of the present study, we speculate that EA at
ST36 may have an anti-inflammatory and anti-arthritic effect
on CIA via suppressing autoimmunity and modulating
immune abnormality. The mechanism of these effects is not
clear yet. Involvement of neuro-immune interaction in the
mechanism of acupuncture on immune diseases such as RA is
feasible. Further studies are needed on the mechanisms of
these effects and the applications for human rheumatoid
arthritis.
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